Name: Personalised management of difficult asthma in women (en Inglés)
SKU: 66314944
Price: 1151.35 MXN
Availability: InStock
Author: Louhaichi, Sabrine; Hamdi, Besma; Hamzaoui, Agnès
ISBN: 9786209065361

portada Personalised management of difficult asthma in women (en Inglés)

Personalised management of difficult asthma in women (en Inglés)

Formato

Libro Físico

Editorial

Our Knowledge Publishing

Autor

Louhaichi, Sabrine; Hamdi, Besma; Hamzaoui, Agnès

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x0.4 cm

ISBN13

9786209065361

Personalised management of difficult asthma in women (en Inglés)

Louhaichi, Sabrine; Hamdi, Besma; Hamzaoui, Agnès (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 27 días háb.

$ 2,302.70$ 1,151.35

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 1,151.35

¡Envío Gratis! Llega entre el 02 Oct y el 12 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Personalised management of difficult asthma in women (en Inglés)"

The aim of our study was to demonstrate the value of personalized management of difficult asthma in women. Prospective study including 50 women. Therapeutic interventions were performed. The mean age was 55. At least three aggravating factors were identified in 64% of cases. The measures that targeted these factors were: therapeutic education(66%), hygienic-dietary rules and pump inhibitor(52%), nasal corticosteroid therapy and antihistamines (72%), psychological interview(68%) and continuous positive airway pressure(10%). Asthma control was achieved in 25 patients. Phenotyping of the remaining patients identified TH2 inflammation in 18 and non-TH2 in 7. Treatment according to phenotyping consisted in: increasing inhaled corticosteroid therapy in case of bronchial eosinophilia, adding an anticholinergic in case of severe obstruction, and an anti-leukotriene in case of aspirin intolerance. The ACT score improved from 15.7 to 20.2 (p=0.0001).Personalized management of difficult asthma seems to be effective in our context.